Explore published studies, educational summaries, and peptide-focused research articles connected to performance, recovery, wellness, metabolism, and body composition.
Researchers evaluated retatrutide, a novel triple-hormone receptor agonist that activates GLP-1, GIP, and glucagon receptors, in adults with obesity or overweight without diabetes. The phase 2, randomized, double-blind,…
Research Library
Benefits of Retatrutide for Weight Loss
The New England Journal of Medicine (NEJM)